VaxGen Incorporated

VaxGen were formed to continue development of AIDSVAX in partnership with Genentech. In connection with our formation, Genentech licensed to us the technology necessary for completing development and commercialization of AIDSVAX.

Contact Details: 1000 Marina Blvd., Suite 200 Brisbane CA 94005 United States of America Tel: 650 624 1000 Fax: Email: WWW: www.vaxgen.com/

Loading...

Recent Publications by VaxGen Incorporated:
Leachables evaluation for bulk drug substance. This study describes a comprehensive analytical approach for evaluating...	12th August, 2009	VaxGen, Inc., South San	PDA J Pharm Sci Technol. 2009 Mar-Apr;63(2):168-83.
LC16m8: an attenuated smallpox vaccine. The frequency of moderate to severe adverse reactions associated with...	5th January, 2007		Vaccine. 2006 Nov 17;24(47-48):7009-22. Epub 2006 Apr 21. DOI Direct Link
High incidence of unusual cysteine variants in gp120 envelope proteins from early HIV type 1 infections from a Phase 3 vaccine efficacy trial. During the course of a large-scale HIV-1 vaccine field trial (VAX004),...	9th December, 2006	VaxGen Inc., South San Francisco, California 94080, USA.	AIDS Res Hum Retroviruses. 2006 Oct;22(10):1014-21. DOI Direct Link
Longitudinal population analysis of dual infection with recombination in two strains of HIV type 1 subtype B in an individual from a Phase 3 HIV vaccine efficacy trial. This study documents a case of coinfection (simultaneous infection of an...	9th December, 2006	VaxGen, Inc., South San Francisco, California 94080, USA.	AIDS Res Hum Retroviruses. 2006 Oct;22(10):968-78. DOI Direct Link
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge. The possible reemergence of smallpox through bioterrorism requires the...	16th June, 2006	VaxGen Inc., 347 Oyster Point Boulevard, Suite 102, South San Francisco,	Vaccine. 2006 Apr 24;24(17):3686-94. DOI Direct Link
→View more VaxGen Incorporated research publications.

BioNews Results for VaxGen Incorporated:
Breaking news - New vaccine to prevent HIV	I-Newswire:  Nov 5 2009 6:30PM Matching: vaxgen
First Signs of AIDS Vaccine Success	Gay City News:  Oct 31 2009 1:09PM Matching: vaxgen
Implementing Platform Approaches to Streamline the Design, Operation and Validation of Biopharmaceutical Facilities	nanotechweb.org:  Oct 30 2009 11:26PM Matching: vaxgen
Will Oxigene's Bid for VaxGen Fare Better Than Raven's Try?	BioWorld Financial Watch:  Oct 30 2009 9:10PM Matching: vaxgen
Week of Oct. 26, 2009: OXiGENE to Acquire VaxGen; Warner Chilcott Appoints Global R&D President; More	Pharmaceutical Technology:  Oct 29 2009 3:21PM Matching: vaxgen
Promote your company here: BioNewsCast - Press Release Distribution	→View more VaxGen Incorporated news.

VaxGen Incorporated Clinical Trials:
A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines

VaxGen Incorporated (VXGN) Financial information Links from Barchart
VXGN Quote from from Barchart.com
VXGN Chart from from Barchart.com
VXGN Profile from from Barchart.com
VXGN Opinion from from Barchart.com
→View more VaxGen Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 268 times since April 2007, the link to the organisation's website has been followed 41 times

Search for more companies in Brisbane

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for VaxGen Incorporated